Skip to content
Screener

AMN Healthcare AMN Treasury stock, shares acquired, average cost per share excluding accelerated share repurchases (in dollars per share)

Treasury stock, shares acquired, average cost per share excluding accelerated share repurchases (in dollars per share) at other companies

Burford Capital logo
Burford CapitalBUR
$12.71-9.6%
Burford Capital logo
Burford CapitalBUR
$12.71-9.6%
VeriSign logo
VeriSignVRSN
$275.00+3.9%
Kaltura, Inc. logo
Kaltura, Inc.KLTR
$0
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$0.020.0%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$0.020.0%

Other financials

Income statement

See full
Revenue$673.2M+2.3%
Gross profit$205.9M+4.8%
Operating income$26.9M+122%
Net income$19.9M+115%
EPS (diluted)$0.53+118%

Balance sheet

See full
Cash & equivalents$390.5M+439%
Total debt$775.8M-12.4%
Total equity$741.3M+22.0%
Total assets$2.4B+6.9%

Cash flow

See full
Operating cash flow$562.5M+507%
CapEx$8.5M-12.9%
Free cash flow$555.2M+571%

Valuation

See full
Market cap$1.4B+121%
Enterprise value$1.78B+23.3%
P/E8.5×
P/S0.4×+0.2×

Profitability

See full
Gross margin27.8%-2.1pp
Operating margin-9.8%-14.2pp
Net margin4.8%+2.8pp
FCF margin20.7%+11.6pp

Returns & leverage

See full
Return on equity24.3%+14.7pp
Debt / equity-0.4×
Current ratio1.1×+0.1×

Where this comes from

Reported directly by AMN Healthcare in its filing.

Tagged under the XBRL concept amn:TreasuryStockSharesAcquiredAverageCostPerShareExcludingAcceleratedShareRepurchases.

The source filing: AMN Healthcare’s 10-K, filed February 20, 2026.

Filed
Feb 19, 2026, 7:00 PM EST
Fiscal year
FY2025
Accession
0001628280-26-009918

During the year ended December 31, 2023, the Company repurchased 2,362 shares of its common stock through the open market at an average price of $95.13 per share (excluding broker’s fees) for an aggregate purchase price of $224,744 (excluding the effect of excise taxes). Additionally, on May 8, 2023, the Company entered into an accelerated share repurchase (“ASR”) agreement with a counterparty whereupon the Company prepaid $200,000 and received an initial delivery of 1,760 shares of its common stock, which was 80% of the prepayment amount based on a price of $90.89 per share. On August 10, 2023, the Company received a final delivery of approximately 261 additional shares of its common stock, representing the remaining 20% of the prepayment and the final settlement of the ASR agreement. The total number of shares received and average price per share of $98.97 was based on the volume-weighted average price over the term of the ASR agreement, less an agreed upon discount. The Company recognized the shares delivered pursuant to the ASR as increases to treasury stock in the consolidated statements of stockholders’ equity during the year ended December 31, 2023.

Item 8. Financial Statements and Supplementary Data

FAQ

What is AMN Healthcare's treasury stock, shares acquired, average cost per share excluding accelerated share repurchases (in dollars per share)?
AMN Healthcare (AMN) reported treasury stock, shares acquired, average cost per share excluding accelerated share repurchases (in dollars per share) of $23.78 in Q4 2023.
What does treasury stock, shares acquired, average cost per share excluding accelerated share repurchases (in dollars per share) mean?
Treasury stock, shares acquired, average cost per share excluding accelerated share repurchases (in dollars per share) as reported by AMN Healthcare Services.

Ask your AI about AMN Healthcare's treasury stock, shares acquired, average cost per share excluding accelerated share repurchases (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude